Informační systém MU
BENES, Petr, Aruna VASHISHTA, Sujata SARASWAT-OHRI, Martin FUSEK, Sarka POSPISILOVA, Boris TICHY and Vaclav VETVICKA. Effect of procathepsin D activation peptide on gene expression of breast cancer cells. Cancer Letters. OXFORD: ELSEVIER, 2006, vol. 239, No 1, p. 46-54. ISSN 0304-3835.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Effect of procathepsin D activation peptide on gene expression of breast cancer cells
Name in Czech Vliv aktivačního peptidu prokatepsinu D na genovou expresi buněk karcinomu prsu
Authors BENES, Petr (203 Czech Republic, guarantor), Aruna VASHISHTA (356 India), Sujata SARASWAT-OHRI (356 India), Martin FUSEK (203 Czech Republic), Sarka POSPISILOVA (203 Czech Republic), Boris TICHY (203 Czech Republic) and Vaclav VETVICKA (203 Czech Republic).
Edition Cancer Letters, OXFORD, ELSEVIER, 2006, 0304-3835.
Other information
Original language English
Type of outcome Article in a journal
Field of Study Genetics and molecular biology
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 3.277
RIV identification code RIV/00216224:14310/06:00016569
Organization unit Faculty of Science
UT WoS 000239553500006
Keywords in English Breast cancer; Gene expression; Microarray analysis; Procathepsin D
Tags breast cancer, GENE EXPRESSION, microarray analysis, procathepsin D
Tags International impact, Reviewed
Changed by Changed by: prof. RNDr. Šárka Pospíšilová, Ph.D., učo 38791. Changed: 18/6/2009 18:12.
Abstract
Overexpression of procathepsin D (pCD) is reported to occur in numerous types of cancer and is associated with increased growth and metastasis. It has been established that pCD affects multiple stages of tumor progression including proliferation, angiogenesis and metastasis. Previously, we showed that the mitogenic effect of pCD on cancer cells is mediated by interaction of its activation peptide (AP) with yet unidentified cell surface receptor. In this investigation, gene expression profiles were compared between AP-treated and control human breast cancer ZR-75-1 cells to elucidate the mechanism of AP mitogenicity. Several differentially expressed genes involved in signal transduction, regulation of cell cycle, apoptosis, tumor invasion and metastasis were identified using microarray technology. These findings, including overexpression of NFkappaB2, were confirmed in breast cancer cell lines by reverse-transcriptase PCR (RT-PCR). Understanding the mechanism of pCDs effect on breast cancer cells could extend possibilities of breast cancer treatment in the future.
Abstract (in Czech)
Zvýšená exprese prokatepsinu (pCD)je častým jevem u různých typů rakoviny a bývá asociována se zvýšenou proliferací a se zvýšenou četností metastáz. Bylo prokázáno, že pCD ovlivňuje proces tumorigeneze v různých stádiích. Mitogenní efekt pCD na rakovinové buňky je zprostředkován interakcí jeho aktivačního peptidu (AP) s dosud neidentifikovaným povrchovým receptorem. V této práci jsme porovnali pomocí technologie genový čipů genovou expresi mezi buňkami rakoviny prsu ZR-75-1 ovlivněnými AP a kontrolními buňkami. Identifikovali jsme několik různě exprimovaných genů, které se uplatňují v signální transdukci, regulaci buněčného cyklu, apoptóze, invazivitě a metastázování nádorů. Pochopení mechanismu účinku pCD na buňky rakoviny prsu může v budoucnosti rozšířit možnosti onkologické terapie.
Links
MSM0021622415, plan (intention)Name: Molekulární podstata buněčných a tkáňových regulací
Investor: Ministry of Education, Youth and Sports of the CR, Molecular basis of cell and tissue regulations
Displayed: 20/7/2024 10:18